what is in ro compounded semaglutide Weight Loss: Step-by-Step Guide to FDA-Approved GLP-1 Treatments Including Wegovy, Ozempic, and Zepbound Compounded Semaglutide vs. Ozempic: Are

Nobody is surprised that diabetes medications improve diabetes or even heart disease

Deficiency rates in GLP-1 users, per Butsch et al., 2025: vitamin D 7.5% at 6 months rising to 13.6% at 12 months

Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ

Even for employers betting that the potential long-term health benefits associated with GLP-1 utilizations and weight loss - including reduced risks for cardiovascular and kidney disease - will ultimately outweigh the substantial upfront costs, those rising upfront costs are becoming problematic

Summary: Yes, Wegovy (semaglutide 2.4 mg) can cause headaches as a common adverse effect, typically emerging during initial treatment weeks and dose escalation